世界の化学療法誘発性貧血治療薬市場インサイト及び予測(~2026年)

【英語タイトル】Global Chemotherapy Induced Anemia Drug Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV00176)・商品コード:QYR20NV00176
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは化学療法誘発性貧血治療薬の世界市場について調査・分析した資料です。種類別(エポエチンゼータバイオシミラー、鉄カルボキシマルトース、ペグ化エリスロポエチン、その他)の市場規模、用途別(クリニック、病院、在宅医療)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別化学療法誘発性貧血治療薬の競争状況、市場シェア
・世界の化学療法誘発性貧血治療薬市場:種類別市場規模 2015年-2020年(エポエチンゼータバイオシミラー、鉄カルボキシマルトース、ペグ化エリスロポエチン、その他)
・世界の化学療法誘発性貧血治療薬市場:種類別市場規模予測 2021年-2026年(エポエチンゼータバイオシミラー、鉄カルボキシマルトース、ペグ化エリスロポエチン、その他)
・世界の化学療法誘発性貧血治療薬市場:用途別市場規模 2015年-2020年(クリニック、病院、在宅医療)
・世界の化学療法誘発性貧血治療薬市場:用途別市場規模予測 2021年-2026年(クリニック、病院、在宅医療)
・北米の化学療法誘発性貧血治療薬市場分析:米国、カナダ
・ヨーロッパの化学療法誘発性貧血治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの化学療法誘発性貧血治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の化学療法誘発性貧血治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの化学療法誘発性貧血治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):3SBio Inc.、BIOCAD、Chong Kun Dang Pharmaceutical Corp.、Dr. Reddy's Laboratories Limited、Galenica Ltd.、Panacea Biotec Limited、Pfizer Inc.、PharmaEssentia Corporation、PhytoHealth Corporation、Pieris Pharmaceuticals Inc、Sandoz International GmbH、SBI Pharmaceuticals Co., Ltd.、Therapure Biopharma Inc.、Tolero Pharmaceuticals, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Chemotherapy Induced Anemia Drug Market
The global Chemotherapy Induced Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chemotherapy Induced Anemia Drug Scope and Market Size
Chemotherapy Induced Anemia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Anemia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Chemotherapy Induced Anemia Drug market is segmented into
Epoetin Zeta Biosimilar
Ferric Carboxymaltose
Pegylated Erythropoietin
Others

Segment by Application, the Chemotherapy Induced Anemia Drug market is segmented into
Clinic
Hospital
Homecare

Regional and Country-level Analysis
The Chemotherapy Induced Anemia Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chemotherapy Induced Anemia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chemotherapy Induced Anemia Drug Market Share Analysis
Chemotherapy Induced Anemia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chemotherapy Induced Anemia Drug business, the date to enter into the Chemotherapy Induced Anemia Drug market, Chemotherapy Induced Anemia Drug product introduction, recent developments, etc.

The major vendors covered:
3SBio Inc.
BIOCAD
Chong Kun Dang Pharmaceutical Corp.
Dr. Reddy’s Laboratories Limited
Galenica Ltd.
Panacea Biotec Limited
Pfizer Inc.
PharmaEssentia Corporation
PhytoHealth Corporation
Pieris Pharmaceuticals Inc
Sandoz International GmbH
SBI Pharmaceuticals Co., Ltd.
Therapure Biopharma Inc.
Tolero Pharmaceuticals, Inc.

【レポートの目次】

1 Study Coverage
1.1 Chemotherapy Induced Anemia Drug Product Introduction
1.2 Market Segments
1.3 Key Chemotherapy Induced Anemia Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chemotherapy Induced Anemia Drug Market Size Growth Rate by Type
1.4.2 Epoetin Zeta Biosimilar
1.4.3 Ferric Carboxymaltose
1.4.4 Pegylated Erythropoietin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chemotherapy Induced Anemia Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chemotherapy Induced Anemia Drug Market Size, Estimates and Forecasts
2.1.1 Global Chemotherapy Induced Anemia Drug Revenue 2015-2026
2.1.2 Global Chemotherapy Induced Anemia Drug Sales 2015-2026
2.2 Global Chemotherapy Induced Anemia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chemotherapy Induced Anemia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chemotherapy Induced Anemia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Chemotherapy Induced Anemia Drug Competitor Landscape by Players
3.1 Chemotherapy Induced Anemia Drug Sales by Manufacturers
3.1.1 Chemotherapy Induced Anemia Drug Sales by Manufacturers (2015-2020)
3.1.2 Chemotherapy Induced Anemia Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Chemotherapy Induced Anemia Drug Revenue by Manufacturers
3.2.1 Chemotherapy Induced Anemia Drug Revenue by Manufacturers (2015-2020)
3.2.2 Chemotherapy Induced Anemia Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chemotherapy Induced Anemia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chemotherapy Induced Anemia Drug Revenue in 2019
3.2.5 Global Chemotherapy Induced Anemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chemotherapy Induced Anemia Drug Price by Manufacturers
3.4 Chemotherapy Induced Anemia Drug Manufacturing Base Distribution, Product Types
3.4.1 Chemotherapy Induced Anemia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemotherapy Induced Anemia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Chemotherapy Induced Anemia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chemotherapy Induced Anemia Drug Market Size by Type (2015-2020)
4.1.1 Global Chemotherapy Induced Anemia Drug Sales by Type (2015-2020)
4.1.2 Global Chemotherapy Induced Anemia Drug Revenue by Type (2015-2020)
4.1.3 Chemotherapy Induced Anemia Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chemotherapy Induced Anemia Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Chemotherapy Induced Anemia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Chemotherapy Induced Anemia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Chemotherapy Induced Anemia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chemotherapy Induced Anemia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chemotherapy Induced Anemia Drug Market Size by Application (2015-2020)
5.1.1 Global Chemotherapy Induced Anemia Drug Sales by Application (2015-2020)
5.1.2 Global Chemotherapy Induced Anemia Drug Revenue by Application (2015-2020)
5.1.3 Chemotherapy Induced Anemia Drug Price by Application (2015-2020)
5.2 Chemotherapy Induced Anemia Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Chemotherapy Induced Anemia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Chemotherapy Induced Anemia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Chemotherapy Induced Anemia Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Chemotherapy Induced Anemia Drug by Country
6.1.1 North America Chemotherapy Induced Anemia Drug Sales by Country
6.1.2 North America Chemotherapy Induced Anemia Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chemotherapy Induced Anemia Drug Market Facts & Figures by Type
6.3 North America Chemotherapy Induced Anemia Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Chemotherapy Induced Anemia Drug by Country
7.1.1 Europe Chemotherapy Induced Anemia Drug Sales by Country
7.1.2 Europe Chemotherapy Induced Anemia Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chemotherapy Induced Anemia Drug Market Facts & Figures by Type
7.3 Europe Chemotherapy Induced Anemia Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Chemotherapy Induced Anemia Drug by Region
8.1.1 Asia Pacific Chemotherapy Induced Anemia Drug Sales by Region
8.1.2 Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chemotherapy Induced Anemia Drug Market Facts & Figures by Type
8.3 Asia Pacific Chemotherapy Induced Anemia Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Chemotherapy Induced Anemia Drug by Country
9.1.1 Latin America Chemotherapy Induced Anemia Drug Sales by Country
9.1.2 Latin America Chemotherapy Induced Anemia Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chemotherapy Induced Anemia Drug Market Facts & Figures by Type
9.3 Central & South America Chemotherapy Induced Anemia Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Chemotherapy Induced Anemia Drug by Country
10.1.1 Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country
10.1.2 Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chemotherapy Induced Anemia Drug Market Facts & Figures by Type
10.3 Middle East and Africa Chemotherapy Induced Anemia Drug Market Facts & Figures by Application

11 Company Profiles
11.1 3SBio Inc.
11.1.1 3SBio Inc. Corporation Information
11.1.2 3SBio Inc. Description and Business Overview
11.1.3 3SBio Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc. Chemotherapy Induced Anemia Drug Products Offered
11.1.5 3SBio Inc. Related Developments
11.2 BIOCAD
11.2.1 BIOCAD Corporation Information
11.2.2 BIOCAD Description and Business Overview
11.2.3 BIOCAD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BIOCAD Chemotherapy Induced Anemia Drug Products Offered
11.2.5 BIOCAD Related Developments
11.3 Chong Kun Dang Pharmaceutical Corp.
11.3.1 Chong Kun Dang Pharmaceutical Corp. Corporation Information
11.3.2 Chong Kun Dang Pharmaceutical Corp. Description and Business Overview
11.3.3 Chong Kun Dang Pharmaceutical Corp. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Products Offered
11.3.5 Chong Kun Dang Pharmaceutical Corp. Related Developments
11.4 Dr. Reddy’s Laboratories Limited
11.4.1 Dr. Reddy’s Laboratories Limited Corporation Information
11.4.2 Dr. Reddy’s Laboratories Limited Description and Business Overview
11.4.3 Dr. Reddy’s Laboratories Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dr. Reddy’s Laboratories Limited Chemotherapy Induced Anemia Drug Products Offered
11.4.5 Dr. Reddy’s Laboratories Limited Related Developments
11.5 Galenica Ltd.
11.5.1 Galenica Ltd. Corporation Information
11.5.2 Galenica Ltd. Description and Business Overview
11.5.3 Galenica Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Galenica Ltd. Chemotherapy Induced Anemia Drug Products Offered
11.5.5 Galenica Ltd. Related Developments
11.6 Panacea Biotec Limited
11.6.1 Panacea Biotec Limited Corporation Information
11.6.2 Panacea Biotec Limited Description and Business Overview
11.6.3 Panacea Biotec Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Products Offered
11.6.5 Panacea Biotec Limited Related Developments
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Corporation Information
11.7.2 Pfizer Inc. Description and Business Overview
11.7.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Inc. Chemotherapy Induced Anemia Drug Products Offered
11.7.5 Pfizer Inc. Related Developments
11.8 PharmaEssentia Corporation
11.8.1 PharmaEssentia Corporation Corporation Information
11.8.2 PharmaEssentia Corporation Description and Business Overview
11.8.3 PharmaEssentia Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Products Offered
11.8.5 PharmaEssentia Corporation Related Developments
11.9 PhytoHealth Corporation
11.9.1 PhytoHealth Corporation Corporation Information
11.9.2 PhytoHealth Corporation Description and Business Overview
11.9.3 PhytoHealth Corporation Sales, Revenue and Gross Margin (2015-2020)
11.9.4 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Products Offered
11.9.5 PhytoHealth Corporation Related Developments
11.10 Pieris Pharmaceuticals Inc
11.10.1 Pieris Pharmaceuticals Inc Corporation Information
11.10.2 Pieris Pharmaceuticals Inc Description and Business Overview
11.10.3 Pieris Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Products Offered
11.10.5 Pieris Pharmaceuticals Inc Related Developments
11.1 3SBio Inc.
11.1.1 3SBio Inc. Corporation Information
11.1.2 3SBio Inc. Description and Business Overview
11.1.3 3SBio Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc. Chemotherapy Induced Anemia Drug Products Offered
11.1.5 3SBio Inc. Related Developments
11.12 SBI Pharmaceuticals Co., Ltd.
11.12.1 SBI Pharmaceuticals Co., Ltd. Corporation Information
11.12.2 SBI Pharmaceuticals Co., Ltd. Description and Business Overview
11.12.3 SBI Pharmaceuticals Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 SBI Pharmaceuticals Co., Ltd. Products Offered
11.12.5 SBI Pharmaceuticals Co., Ltd. Related Developments
11.13 Therapure Biopharma Inc.
11.13.1 Therapure Biopharma Inc. Corporation Information
11.13.2 Therapure Biopharma Inc. Description and Business Overview
11.13.3 Therapure Biopharma Inc. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Therapure Biopharma Inc. Products Offered
11.13.5 Therapure Biopharma Inc. Related Developments
11.14 Tolero Pharmaceuticals, Inc.
11.14.1 Tolero Pharmaceuticals, Inc. Corporation Information
11.14.2 Tolero Pharmaceuticals, Inc. Description and Business Overview
11.14.3 Tolero Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Tolero Pharmaceuticals, Inc. Products Offered
11.14.5 Tolero Pharmaceuticals, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chemotherapy Induced Anemia Drug Market Estimates and Projections by Region
12.1.1 Global Chemotherapy Induced Anemia Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Chemotherapy Induced Anemia Drug Revenue Forecast by Regions 2021-2026
12.2 North America Chemotherapy Induced Anemia Drug Market Size Forecast (2021-2026)
12.2.1 North America: Chemotherapy Induced Anemia Drug Sales Forecast (2021-2026)
12.2.2 North America: Chemotherapy Induced Anemia Drug Revenue Forecast (2021-2026)
12.2.3 North America: Chemotherapy Induced Anemia Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Chemotherapy Induced Anemia Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Chemotherapy Induced Anemia Drug Sales Forecast (2021-2026)
12.3.2 Europe: Chemotherapy Induced Anemia Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Chemotherapy Induced Anemia Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chemotherapy Induced Anemia Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chemotherapy Induced Anemia Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chemotherapy Induced Anemia Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chemotherapy Induced Anemia Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Chemotherapy Induced Anemia Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Chemotherapy Induced Anemia Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Chemotherapy Induced Anemia Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Chemotherapy Induced Anemia Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chemotherapy Induced Anemia Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chemotherapy Induced Anemia Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chemotherapy Induced Anemia Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chemotherapy Induced Anemia Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chemotherapy Induced Anemia Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chemotherapy Induced Anemia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Chemotherapy Induced Anemia Drug Market Segments
Table 2. Ranking of Global Top Chemotherapy Induced Anemia Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chemotherapy Induced Anemia Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Epoetin Zeta Biosimilar
Table 5. Major Manufacturers of Ferric Carboxymaltose
Table 6. Major Manufacturers of Pegylated Erythropoietin
Table 7. Major Manufacturers of Others
Table 8. Global Chemotherapy Induced Anemia Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Chemotherapy Induced Anemia Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Chemotherapy Induced Anemia Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Chemotherapy Induced Anemia Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Chemotherapy Induced Anemia Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Chemotherapy Induced Anemia Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Chemotherapy Induced Anemia Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Chemotherapy Induced Anemia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Chemotherapy Induced Anemia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Anemia Drug as of 2019)
Table 17. Chemotherapy Induced Anemia Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Chemotherapy Induced Anemia Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Chemotherapy Induced Anemia Drug Price (2015-2020) (USD/Pcs)
Table 20. Chemotherapy Induced Anemia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Chemotherapy Induced Anemia Drug Product Type
Table 22. Date of International Manufacturers Enter into Chemotherapy Induced Anemia Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Chemotherapy Induced Anemia Drug Sales Share by Type (2015-2020)
Table 26. Global Chemotherapy Induced Anemia Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Chemotherapy Induced Anemia Drug Revenue Share by Type (2015-2020)
Table 28. Chemotherapy Induced Anemia Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Chemotherapy Induced Anemia Drug Sales Share by Application (2015-2020)
Table 31. North America Chemotherapy Induced Anemia Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2015-2020)
Table 33. North America Chemotherapy Induced Anemia Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Table 37. North America Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Chemotherapy Induced Anemia Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Chemotherapy Induced Anemia Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Chemotherapy Induced Anemia Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Chemotherapy Induced Anemia Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Chemotherapy Induced Anemia Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Chemotherapy Induced Anemia Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Table 71. 3SBio Inc. Corporation Information
Table 72. 3SBio Inc. Description and Major Businesses
Table 73. 3SBio Inc. Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. 3SBio Inc. Product
Table 75. 3SBio Inc. Recent Development
Table 76. BIOCAD Corporation Information
Table 77. BIOCAD Description and Major Businesses
Table 78. BIOCAD Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. BIOCAD Product
Table 80. BIOCAD Recent Development
Table 81. Chong Kun Dang Pharmaceutical Corp. Corporation Information
Table 82. Chong Kun Dang Pharmaceutical Corp. Description and Major Businesses
Table 83. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Chong Kun Dang Pharmaceutical Corp. Product
Table 85. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 86. Dr. Reddy's Laboratories Limited Corporation Information
Table 87. Dr. Reddy's Laboratories Limited Description and Major Businesses
Table 88. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Dr. Reddy's Laboratories Limited Product
Table 90. Dr. Reddy's Laboratories Limited Recent Development
Table 91. Galenica Ltd. Corporation Information
Table 92. Galenica Ltd. Description and Major Businesses
Table 93. Galenica Ltd. Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Galenica Ltd. Product
Table 95. Galenica Ltd. Recent Development
Table 96. Panacea Biotec Limited Corporation Information
Table 97. Panacea Biotec Limited Description and Major Businesses
Table 98. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Panacea Biotec Limited Product
Table 100. Panacea Biotec Limited Recent Development
Table 101. Pfizer Inc. Corporation Information
Table 102. Pfizer Inc. Description and Major Businesses
Table 103. Pfizer Inc. Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Pfizer Inc. Product
Table 105. Pfizer Inc. Recent Development
Table 106. PharmaEssentia Corporation Corporation Information
Table 107. PharmaEssentia Corporation Description and Major Businesses
Table 108. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. PharmaEssentia Corporation Product
Table 110. PharmaEssentia Corporation Recent Development
Table 111. PhytoHealth Corporation Corporation Information
Table 112. PhytoHealth Corporation Description and Major Businesses
Table 113. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. PhytoHealth Corporation Product
Table 115. PhytoHealth Corporation Recent Development
Table 116. Pieris Pharmaceuticals Inc Corporation Information
Table 117. Pieris Pharmaceuticals Inc Description and Major Businesses
Table 118. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Pieris Pharmaceuticals Inc Product
Table 120. Pieris Pharmaceuticals Inc Recent Development
Table 121. Sandoz International GmbH Corporation Information
Table 122. Sandoz International GmbH Description and Major Businesses
Table 123. Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Sandoz International GmbH Product
Table 125. Sandoz International GmbH Recent Development
Table 126. SBI Pharmaceuticals Co., Ltd. Corporation Information
Table 127. SBI Pharmaceuticals Co., Ltd. Description and Major Businesses
Table 128. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. SBI Pharmaceuticals Co., Ltd. Product
Table 130. SBI Pharmaceuticals Co., Ltd. Recent Development
Table 131. Therapure Biopharma Inc. Corporation Information
Table 132. Therapure Biopharma Inc. Description and Major Businesses
Table 133. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. Therapure Biopharma Inc. Product
Table 135. Therapure Biopharma Inc. Recent Development
Table 136. Tolero Pharmaceuticals, Inc. Corporation Information
Table 137. Tolero Pharmaceuticals, Inc. Description and Major Businesses
Table 138. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 139. Tolero Pharmaceuticals, Inc. Product
Table 140. Tolero Pharmaceuticals, Inc. Recent Development
Table 141. Global Chemotherapy Induced Anemia Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 142. Global Chemotherapy Induced Anemia Drug Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Chemotherapy Induced Anemia Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Chemotherapy Induced Anemia Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Chemotherapy Induced Anemia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. North America: Chemotherapy Induced Anemia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Chemotherapy Induced Anemia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 148. Europe: Chemotherapy Induced Anemia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Chemotherapy Induced Anemia Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 150. Asia Pacific: Chemotherapy Induced Anemia Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Chemotherapy Induced Anemia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Latin America: Chemotherapy Induced Anemia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Chemotherapy Induced Anemia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 154. Middle East and Africa: Chemotherapy Induced Anemia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Chemotherapy Induced Anemia Drug Players
Table 159. Chemotherapy Induced Anemia Drug Customers List
Table 160. Chemotherapy Induced Anemia Drug Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy Induced Anemia Drug Product Picture
Figure 2. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Epoetin Zeta Biosimilar Product Picture
Figure 4. Ferric Carboxymaltose Product Picture
Figure 5. Pegylated Erythropoietin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Homecare
Figure 11. Chemotherapy Induced Anemia Drug Report Years Considered
Figure 12. Global Chemotherapy Induced Anemia Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Chemotherapy Induced Anemia Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Chemotherapy Induced Anemia Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region in 2019
Figure 17. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region in 2019
Figure 19. Global Chemotherapy Induced Anemia Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Chemotherapy Induced Anemia Drug Revenue in 2019
Figure 21. Chemotherapy Induced Anemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type in 2019
Figure 24. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type in 2019
Figure 26. Global Chemotherapy Induced Anemia Drug Market Share by Price Range (2015-2020)
Figure 27. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application in 2019
Figure 29. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application in 2019
Figure 31. North America Chemotherapy Induced Anemia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Chemotherapy Induced Anemia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Chemotherapy Induced Anemia Drug Sales Market Share by Country in 2019
Figure 34. North America Chemotherapy Induced Anemia Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Chemotherapy Induced Anemia Drug Market Share by Type in 2019
Figure 40. North America Chemotherapy Induced Anemia Drug Market Share by Application in 2019
Figure 41. Europe Chemotherapy Induced Anemia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Chemotherapy Induced Anemia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Country in 2019
Figure 44. Europe Chemotherapy Induced Anemia Drug Revenue Market Share by Country in 2019
Figure 45. Germany Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Chemotherapy Induced Anemia Drug Market Share by Type in 2019
Figure 56. Europe Chemotherapy Induced Anemia Drug Market Share by Application in 2019
Figure 57. Asia Pacific Chemotherapy Induced Anemia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Chemotherapy Induced Anemia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Chemotherapy Induced Anemia Drug Revenue Market Share by Region in 2019
Figure 61. China Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Chemotherapy Induced Anemia Drug Market Share by Type in 2019
Figure 84. Asia Pacific Chemotherapy Induced Anemia Drug Market Share by Application in 2019
Figure 85. Latin America Chemotherapy Induced Anemia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Chemotherapy Induced Anemia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Chemotherapy Induced Anemia Drug Sales Market Share by Country in 2019
Figure 88. Latin America Chemotherapy Induced Anemia Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Chemotherapy Induced Anemia Drug Market Share by Type in 2019
Figure 96. Latin America Chemotherapy Induced Anemia Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Chemotherapy Induced Anemia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Chemotherapy Induced Anemia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Chemotherapy Induced Anemia Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Chemotherapy Induced Anemia Drug Market Share by Application in 2019
Figure 109. North America Chemotherapy Induced Anemia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Chemotherapy Induced Anemia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Chemotherapy Induced Anemia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Chemotherapy Induced Anemia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Chemotherapy Induced Anemia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Chemotherapy Induced Anemia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Chemotherapy Induced Anemia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Chemotherapy Induced Anemia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Chemotherapy Induced Anemia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Chemotherapy Induced Anemia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed


【掲載企業】

3SBio Inc.、BIOCAD、Chong Kun Dang Pharmaceutical Corp.、Dr. Reddy's Laboratories Limited、Galenica Ltd.、Panacea Biotec Limited、Pfizer Inc.、PharmaEssentia Corporation、PhytoHealth Corporation、Pieris Pharmaceuticals Inc、Sandoz International GmbH、SBI Pharmaceuticals Co., Ltd.、Therapure Biopharma Inc.、Tolero Pharmaceuticals, Inc.

★調査レポート[世界の化学療法誘発性貧血治療薬市場インサイト及び予測(~2026年)] (コード:QYR20NV00176)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の化学療法誘発性貧血治療薬市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆